Gritstone Oncology's Series A Round

Gritstone Oncology raised a round of funding on October 20, 2015.

Gritstone Oncology (NASDAQ Global: GRTS) is a personalized cancer immunotherapy company that is advancing the field of immuno-oncology to fight cancer in patients with the most difficult-to-treat tumo…

Articles about Gritstone Oncology's Series A Round: